Search

You searched for "vascularisation"

348 results found

The results of the last survey Dec22

1 December 2022 | | Ophthalmology
I am regularly faced with litigation whereby the claimant’s cornea has decompensated after cataract surgery. The procedure may have been complicated but sometimes it is not. The eye may have been high risk, for example, a shallow anterior chamber with...

Winner announced for the Silmo IOA International Optician of the Year Award

5 October 2023 | IOA, Jean-François Porte, Silmo, Competition, Opticians, Donald Crichton, SILMO 2024
The International Opticians Association (IOA) has announced the winner of the Silmo IOA International Optician of the Year Award. This innovative award recognises the importance of the optician in the optical business and their role in the choice of optimum products for their clientele.

The future of binocular viewing systems?

1 December 2022 | | Ophthalmology
I recently had the pleasure to visit Vision Engineering’s headquarters and manufacturing facility in Woking, UK. Vision Engineering have built an international reputation for engineering microscopes that provide 3D visualisation without the use of traditional optical eyepieces. Although the company...

The art of ophthalmic simulations

4 December 2023 | | Imaging
For Dec/Jan 2024, I got in touch with Nicky Webster, a Principal 3D Artist at FundamentalVR (https://fundamentalsurgery.com). Nicky is also a registered medical illustrator, healthcare scientist and medical photographer. With over 18 years of experience working in various disciplines within...

What’s new in wet AMD papers?

1 December 2016 | | Retina / Uvea / Vitreous
Paper presentations on neovascular (‘wet’) age-related macular degeneration (AMD) from the 16th European Society of Retina Specialists Congress, Copenhagen, September 2016, outline recent research directions evaluating the impact of vision loss on key health domains, patient preferences in the process...

Intravitreal injections delivered by ophthalmic clinical nurse specialists

1 June 2015 | | Retina / Uvea / Vitreous
Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...

100 years of insulin

3 October 2022 | | Ophthalmology
*Joint first authors The centenary of the discovery of insulin is a time to celebrate one of the most significant scientific discoveries of the 20th century. Background Before 1923, Type 1 diabetes mellitus [T1DM] resulted in death from severe ketoacidosis...

Broadening of treatment options for potentially blinding retinal conditions

2 August 2022 | | Ophthalmology
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...

Twenty-five years in retina

1 February 2019 | | Ophthalmology, Retina / Uvea / Vitreous
In the next of our articles celebrating 25 years of Eye News, the authors look at how the retina specialty has changed over this time and ask what the future might hold. Retinal disease management has benefited from great advances...

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

1 April 2016 | | Cataract and Refractive, Cornea / External Eye Disease, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...

Treatment of diabetic macular oedema

1 June 2014 | | Retina / Uvea / Vitreous
Diabetic macular oedema (DMO) is a common complication associated with diabetic retinopathy, and the most common cause of visual impairment in diabetes [1]. With predicted rising levels of diabetes (in England by 2025 the estimated population with diabetes will be...

What's trending Jun/Jul 2021

3 June 2021 | | Ophthalmology, Optometry, Cataract and Refractive, Cornea / External Eye Disease
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #blindpensioner #teachescooking #cookbook Simon Mahoney lost his eyesight to uveitic glaucoma. His wife was his main carer and did most of...